Detalhe da pesquisa
1.
Efficacy of Recombinant Zoster Vaccine in Patients With Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 20(7): 1570-1578.e1, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34274513
2.
Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study.
Am J Gastroenterol
; 116(4): 808-810, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33982951
3.
Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk.
Am J Gastroenterol
; 116(4): 741-747, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33982944
4.
Repeated Occurrences of Basal Cell Cancer in Patients With Inflammatory Bowel Disease Treated With Immunosuppressive Medications.
Am J Gastroenterol
; 115(8): 1246-1252, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32453047
5.
Adherence of Infusible Biologics During the Time of COVID-19 Among Patients With Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study.
Gastroenterology
; 159(4): 1592-1594.e1, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32574622
6.
Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
J Crohns Colitis
; 16(9): 1505-1507, 2022 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35350070
7.
The impact of IBD medications on risk of pneumonia and pneumonia-related hospitalisation: a nationwide cohort study of 56 410 IBD patients.
Aliment Pharmacol Ther
; 55(1): 64-72, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664313
8.
Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis
; 28(5): 734-744, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245261
9.
Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study.
Adv Ther
; 38(5): 2586-2598, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844132
10.
The Efficacy and Safety of Switching From Originator Infliximab to Single or Double Switch Biosimilar Among a Nationwide Cohort of Inflammatory Bowel Disease Patients.
Crohns Colitis 360
; 3(2): otab022, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36778941